Next-Generation Biomanufacturing Market, By Workflow Type (Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow), By Application (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others), By End-Users (Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Report Code: PMI516923 | Publish Date: March 2024 | No. of Pages: 168

Next Generation Biomanufacturing Market Overview

[PDF] Next-Generation Biomanufacturing help in improving scalability, efficiency, sustainability and cost-effectiveness in manufacturing processes of biologics. New and advanced genomic technologies such as antisense oligonucleotides, mRNA, and cell & gene therapies have boost the demand for biomanufacturing at period of rapid evolution.

Next Generation Biomanufacturing Market Dynamics

Rising demand for biopharmaceuticals to fuel market growth

Biopharmaceutical products are made from living cells and thus, behaves differently as compared to traditional pharmaceutical products. Increasing effectiveness and life expectancy with biopharmaceutical treatment has provided lucrative opportunities in target market growth. Further, growing demand for personalized medicine has given rise in demand for biopharmaceuticals. Furthermore, rising geriatric population coupled with prevalence of chronic diseases across globe has become major driving factors in Next-Generation Biomanufacturing Market growth.

Technological Advancement to fuel market growth

Technological advancement in biomanufacturing has offered production of high quality biologics with increased efficiency and cost-effectiveness. The new emerging technologies such as automation, digitalization, advanced analytics, continuous manufacturing, single-use technologies and others has given positive impact on target market growth.

Restrains:

However, lack of skilled professional and complex manufacturing & development process has hampered the demand for Next-Generation Biomanufacturing Market growth.

Next Generation Biomanufacturing Market Segmentation

Next-Generation Biomanufacturing Market Segmentation:

Next-Generation Biomanufacturing Market is segmented based on Workflow Type, Application, End-Users and Region.

Workflow Type Insight

On the basis of Workflow Type, Next-Generation Biomanufacturing Market is segmented into Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow.

Application Insight

On the basis of Application, Next-Generation Biomanufacturing Market is segmented into Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others.

End-Users Insights

On the basis of End-Users, Next-Generation Biomanufacturing Market is segmented into Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others.

Next-Generation Biomanufacturing Market Regional Insights:

On region the Next-Generation Biomanufacturing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of chronic diseases, continuous technological development, strong-presence of large biopharmaceutical companies, well advanced research institutes and huge investment in research & development activities.

Asia Pacific market is estimated to witness a fastest growth over the forecast period due to rapidly growing population coupled with prevalence of diseases and adoption of advanced technologies.

Report Scope:

Attribute

Details

Base year for estimation

2022

Forecast period

2022 – 2032

Market representation

Revenue in USD Billion & CAGR from 2022 to 2032

Market Segmentation

By Workflow Type - Upstream Workflow, Downstream Workflow, Single-Use Upstream Workflow

By Application - Recombinant Proteins, Monoclonal Antibodies, Vaccines, Hormones, and Others

By End-Users - Research Institutions, Biopharmaceutical Companies, Contract Research Organizations, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.

Next Generation Biomanufacturing Market Key Players

Next-Generation Biomanufacturing Market Key Players:

The key players operating the Next-Generation Biomanufacturing Market includes, Merck & Co., Sartorius AG, ESCO Group LLC., Danaher Corporation, Thermo Fisher Scientific Inc., Meissner Filtration Products Inc., PBS Biotech Inc., Solaris Biotechnology Srl., GEA Group AG, bbi-biotech GmbH, and Others.

Next Generation Biomanufacturing Market Company Profile

  1. Company Profiles
  • Merck & Co.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sartorius AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ESCO Group LLC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Meissner Filtration Products Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PBS Biotech Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Solaris Biotechnology Srl.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GEA Group AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • bbi-biotech GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Recent Development:

 The New Launched Product News,

In June 2023, Samsung Biologics accelerated timeline of its new fifth plant to be operational in April 2025. The company’s second Bio Campus plant 5 will maintain world’s largest capacity of biomanufacturing at 784,000 liters and featured with advanced automation & sustainable systems and provides seamless process integration & optimization.

Next Generation Biomanufacturing Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Workflow Type
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market segmentation, By Workflow Type, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Upstream Workflow
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Downstream Workflow
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Single-Use Upstream Workflow
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Market segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Recombinant Proteins
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Monoclonal Antibodies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Vaccines
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Hormones
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Market segmentation, By End-Users, Forecast Period up to 10 Years, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Segment Trends
    • Research Institutions
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Biopharmaceutical Companies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Contract Research Organizations
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  2. Market segmentation, By Region, Forecast Period up to 10 Years, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Workflow Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Workflow Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Workflow Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Workflow Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Workflow Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis

FAQs

The Next-Generation Biomanufacturing Market is segmented into Workflow Type, Application, End-Users and Region.

Next-Generation Biomanufacturing Market is driven by factors like rising demand for biopharmaceuticals and technological advancement.

By region, the Next-Generation Biomanufacturing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the Next-Generation Biomanufacturing Market includes, Merck & Co., Sartorius AG, ESCO Group LLC., Danaher Corporation, Thermo Fisher Scientific Inc., Meissner Filtration Products Inc., PBS Biotech Inc., Solaris Biotechnology Srl., GEA Group AG, bbi-biotech GmbH, and Others.

Next-Generation Biomanufacturing Market accounted for US$ 19.9 billion in 2022 and is estimated to be US$ 40.9 billion by 2032 and is anticipated to register a CAGR of 7.8%.